BioMarin | Market Exclusive

Home Tags BioMarin

Here’s Our Take On The Latest BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Submission

- July 4, 2017 0

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Scores Big, But Have The Children?

- April 28, 2017 0

A Look At The Science Behind BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s Next...

- October 20, 2016 0

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)’s Setback Isn’t Really A Setback

- September 7, 2016 0

A Look At The Upcoming BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) BLA

- August 5, 2016 0

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is Preparing to Release PEG-PAL Topline

- March 14, 2016 0

The Week’s Biggest Movers: Aduro BioTech Inc (NASDAQ:ADRO) and Sarepta Therapeutics...

- March 11, 2016 0

BioMarin, Sarepta’s Loss Could Be PTC’s Gain

Roger Hannington - January 18, 2016 0

Could the FDA Approve Both BioMarin and Sarepta’s DMD Candidates?

Roger Hannington - December 17, 2015 0

Two Stocks to Watch This Month in Biotech

- December 3, 2015 0

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: BioMarin